Galen Growth + ViVE 2024 Champion Digital Health Innovation as a Salve for an Ailing US Health Ecosystem

Health Information is Both a Maze and Bridge As the World’s Biggest Health System Seeks Solutions to Care Work-Flow and Cost Dilemmas

UPDATED Story with the Galen Growth | 2024 Digital Health Report Issued at ViVE2024

Media colleague Eric Wicklund, associate content manager and senior editor for Innovation, Technology, and Pharma for HealthLeaders, has penned a ViVE preview piece with a power grabber: “CAN VIVE 2024 SOLVE HEALTHCARE’S BIGGEST DILEMMAS?” That headline question isn’t rhetorical and doesn’t require an answer.  Resolution is not the responsibility of the ViVE co-organizers CHIME Health and HLTH.  ViVE puts the collaborative opportunity for health ecosystem players to face the challenges and opportunities in motion.

At the heart of these dilemmas is how payers, patients, product innovators, policymakers, and providers source and maximize health information.  No doubt everyone is jumping on the AI, ChatGPT, and GenAI bandwagon, excited that technology will solve the problems of system-wide fragmentation.  But like any tech shift or bolus of information, it all comes down to what innovation theorist John Nosta calls the “Introduction of the Cognitive Age.”

While some express trepidation that this technological revolution is the dawn of all fears that smart machines will replace health professionals, Nosta suggests that the “Cognitive Age leverages AI as a partner, augmenting and enhancing people’s ability to access and act with heightened intellectual and even technical (i.e., physical ability).

Once again, ViVE has teamed up with Galen Growth to provide insights on digital health in the US health systems. Galen Growth connects the importance of partnership and recent trends influencing not only the US health system – but also the close reader how health information and innovative technologies will transform the delivery, quality, and cost of patient care – including the influence on clinical evidence, decentralized clinical trials, and connective and home care.

Access the Galen Growth 2024 Digital Health Report here: LINK

ViVE is the space where all these conversations – the good, bad, and ugly – of the (predominately US) health ecosystem can be explored, and ideas can be identified and pursued.  VIVE partners with Galen Growth – the global digital health research and analytics specialist. It uses its proprietary database HealthTech AlphaTM to track more than 680 million data points, documenting 14,200 digital health ventures worldwide to produce its “Digital Health Innovation | 2024 Report.”

“In an era of rapid technological advancement, the 6,129 hospitals within 407 Health Systems1 across the United States are at the forefront of transforming healthcare delivery for diverse communities nationwide, notes Julien de Salaberry, a co-founder and CEO of Galen Growth. As the Digital Health landscape evolves, Health Systems play a pivotal role in bridging gaps, enhancing patient outcomes, and addressing persistent pain points.”

Photo Credit: Information from the Galen Growth “Digital Health Innovation | 2024 Report”

But the most significant challenges to accessing the potential of these new digital health technologies are not in ideas themselves – rather the innovators’ understanding of how the US health system works (or is dysfunctional); too often, the founders of these companies are unaware of how to engage leading hospital systems – find champions, integrate within the system, and address cost benefits and ongoing support issues.  Failure to navigate the complexity of countless decision-makers too often leads to ventures running out of capital and vanishing.  The Galen Growth Digital Health Innovation Report documents the roadway to potential success.

CTOs and CIOs within significant health systems are not immune to unprecedented challenges facing hospital economics and the cost of technology. Digital health leaders also recognize that they will hit a brick wall without clearly expressing ROI.  Health systems require measurable outcomes and evidence-based results from digital health partners, and to succeed mutually, they are creating incubators, venture groups and partnership models.

Health systems – hospitals, long-term care communities, and home care providers – will make giant leaps very shortly, drawing on information and technological changes.  The Galen Growth Report issued at ViVE on Monday, February 25th, is the analysis and roadmap to understand better the economic priorities and investments driving these changes.

What is evident from the Galen Growth Digital Health Innovation Report is that while the total dollars of investment in digital health saw a steep decline from the exuberant investment during the height of the COVID pandemic, the category has gained greater importance among health systems seeking to make significant advances in how patient-care, work-flow processes, preventive care and reimbursement analyses play out.

Photo Credit: Information from the Galen Growth “Digital Health Innovation | 2024 Report”

AI, ChatGPT and GenAI investment is not aspirational – the focus is mainly practical and operational.  Those accessing the full report during ViVE will immediately gain valuable information to guide internal planning. Medika Life will update this article tomorrow with a link to the full report.

Will ViVE solve – as Eric Wicklund teases readers – the health system’s “biggest dilemmas?” Is that even it’s mission?  Likely not. But the people who attend ViVE will be looking for insights and information that can guide solutions. The Galen Growth “Digital Health Innovation | 2024 Report” will be one of the big takeaways that will spark conversation, ideas, and hopefully, as Eric reflects, some concrete solutions.


Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

Gil Bashe, Medika Life Editor
Gil Bashe, Medika Life Editor
Health advocate connecting the dots to transform biopharma, digital health and healthcare innovation | Managing Partner, Chair Global Health FINN Partners | MM&M Top 50 Health Influencer | Top 10 Innovation Catalyst. Gil is Medika Life editor-in-chief and an author for the platform’s EcoHealth and Health Opinion and Policy sections. Gil also hosts the HealthcareNOW Radio show Healthunabashed, writes for Health Tech World, and is a member of the BeingWell team on Medium.


Editor in Chief, Medika Life

Meet the Medika Life editor-in-chief, working closely with founding editors Robert Turner and Jeff Livingston, MD.

Not your usual health-industry executive, Gil Bashe has had a unique career shaped by more than three decades in health policy, pharma, life science, digital health, eco-health, environmental innovation and venture capital and informed his determination to ‘give back.’

A champion for health innovation that sustains people’s lives and improves their care, Gil honed his perspectives on both battlefield and boardroom. He started in health as a combat medic in an elite military unit. He went on to serve as a clergyman tending to the ill; as a health products industry lobbyist in environmental affairs; as CEO of one of the world’s largest integrated health marketing companies; as a principal in a private equity-backed venture; as a Medika Life author and Health Tech World correspondent; and as Chair Global Health and Purpose at FINN Partners, a community of purpose dedicated to making a difference.

In the forefront of change, Gil is ranked as a Top 10 Digital Health Influencer; Medical Marketing & Media Top 10 Innovation Catalyst; Medika Life named him a “Top 50 Global Healthcare Influencer,” and PM360 presented him with its “Trailblazer Lifetime Achievement Award.” He is a board member for digital health companies and is an advisor to the CNS Summit, Galien Foundation, Let’s Win for Pancreatic Cancer, Marfan Foundation and other health-centered organizations.





All articles, information and publications featured by the author on thees pages remain the property of the author. Creative Commons does not apply and should you wish to syndicate, copy or reproduce, in part or in full, any of the content from this author, please contact Medika directly.